Quantbot Technologies LP Makes New $438,000 Investment in Azenta, Inc. $AZTA

Quantbot Technologies LP bought a new stake in shares of Azenta, Inc. (NASDAQ:AZTA) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 17,151 shares of the company’s stock, valued at approximately $438,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of AZTA. BlackRock Inc. purchased a new position in Azenta in the second quarter worth about $192,152,000. Vanguard Group Inc. increased its position in shares of Azenta by 2.2% during the 4th quarter. Vanguard Group Inc. now owns 4,538,946 shares of the company’s stock valued at $150,965,000 after purchasing an additional 99,588 shares during the last quarter. Conestoga Capital Advisors LLC increased its position in shares of Azenta by 116.1% during the 1st quarter. Conestoga Capital Advisors LLC now owns 2,844,546 shares of the company’s stock valued at $60,105,000 after purchasing an additional 1,528,145 shares during the last quarter. Millennium Management LLC lifted its stake in shares of Azenta by 9.9% in the 4th quarter. Millennium Management LLC now owns 1,866,531 shares of the company’s stock worth $62,081,000 after purchasing an additional 167,969 shares during the period. Finally, State Street Corp lifted its stake in shares of Azenta by 1.4% in the 4th quarter. State Street Corp now owns 1,732,755 shares of the company’s stock worth $57,631,000 after purchasing an additional 24,062 shares during the period. 99.08% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

AZTA has been the subject of a number of research reports. Needham & Company LLC upped their target price on shares of Azenta from $33.00 to $37.00 and gave the company a “buy” rating in a report on Wednesday, August 5th. Weiss Ratings upgraded shares of Azenta from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday. Four investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $41.20.

Azenta Price Performance

Shares of NASDAQ:AZTA opened at $32.95 on Friday. The company has a market capitalization of $1.44 billion, a P/E ratio of -11.94 and a beta of 1.37. Azenta, Inc. has a 1-year low of $15.93 and a 1-year high of $41.73. The firm’s 50 day simple moving average is $28.93 and its two-hundred day simple moving average is $25.20.

Azenta (NASDAQ:AZTA) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.11 by $0.05. The firm had revenue of $161.18 million during the quarter, compared to analysts’ expectations of $149.31 million. Azenta had a negative net margin of 20.63% and a positive return on equity of 1.18%.

About Azenta

Azenta, Inc (NASDAQ: AZTA) is a life sciences technology company specializing in sample management, cryogenic storage and genomic services for research and clinical applications. Formerly the Life Sciences division of Brooks Automation, Azenta provides integrated solutions that enable customers to store, track and analyze biological samples with high levels of automation, data integrity and efficiency. Its offerings span automated storage systems, biorepository management software and end‐to‐end sample tracking workflows.

In addition to hardware and informatics platforms for sample storage, Azenta’s Genomics business delivers next‐generation sequencing (NGS), DNA synthesis, and molecular biology services.